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Flow cytometric analysis of neoplastic nodules and hepatocellular
carcinomas induced by ciprofibrate in the rat
CL Goolsby and MS Rao
Department ofPathology, VA Lakeside Medical Center, Northwestern University Medical School, Chicago, IL, USA.
Summary Alterations in DNA ploidy accompany hepatocellular carcinoma (HCC). However, changes in
DNA content are also seen in regenerating liver and with increasing age. Thus, to investigate the role of DNA
ploidy changes in development of HCC, flow cytometric DNA content determinations were done in a rat
model system of peroxisome proliferator-induced HCC. Paraffin blocks of liver isolated from 18 Fisher 344
male rats fed ciprofibrate for 20 weeks (4), 40 weeks (4) or 20 months (10) were examined. Livers from
age-matched control rats were also examined. From the 20 month ciprofibrate group, nine neoplastic nodules
(NNs), 27 HCCs and four non-tumorous surrounding tissue controls (NTCs) were examined. Significant DNA
tetraploid populations were seen in both the NNs and NTCs. A significant increase in the percentage of DNA
diploid cells was observed in the NN samples. No significant difference in the percentage S-phase cells was
seen. Emergence of cell populations with new DNA ploidy classes (8c or DNA aneuploid) as compared with
NTCs was only seen in HCCs (7 of 27), and five of these seven were DNA aneuploid, as distinct from DNA
tetraploid, populations. A total of 16 of 24 HCC samples that were adequate for cell cycle analysis had
average percent S-phase greater than the mean of the NTCs plus three standard deviations. Although a direct
role cannot be inferred, these results support the hypothesis that increases in the fraction of diploid cells is an
important early event in the development of rat HCC and that further alterations in DNA ploidy and
increased proliferative fraction accompany the development of HCC.
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Genotoxic and non-genotoxic carcinogens induce hepatocel-
lular carcinomas (HCCs) in rats and mice (Reddy et al.,
1976; Pitot et al., 1978; Williams, 1980; Maronpot and Boor-
man, 1982; Reddy and Lalwani, 1983; Goldsworthy et al.,
1986; Newberne et al., 1987; Rao and Reddy, 1991a). In
these experimental models, irrespective of the type of car-
cinogen used, the development of HCC is preceded by the
formation of altered hepatocyte foci (AHF) and neoplastic
nodules (NNs) (Farber and Cameron, 1980; Pitot and Sirica,
1980; Williams, 1980; Rabes, 1983; Scherer, 1984; Rao et al.,
1984, 1986; Rao and Reddy, 1991b). It is generally believed
that HCCs arise from NNs, although some of them were
shown to develop outside the nodules (Weisburger et al.,
1972). This also appears to be true of HCCs developing in
cirrhotic livers in humans (Arakawa et al., 1986; Terada et
al., 1989). The sequential morphological events that occur
during the development of HCC fits ideally with the notion
that a tumour acquires the malignant phenotype through
sequential multiple genetic changes (Friend et al., 1988).
These changes include abnormal ploidy, oncogene activation
and suppressor-gene inactivation (Cho and Vogelstein, 1992).
The molecular events that take place during the progression
of liver lesions from normal cells to HCC are poorly charac-
terised. In the majority of studies employing genotoxic
agents, an increase in the percent DNA diploid or 2n fraction
of cells has been reported (Schwarze et al., 1984; Styles et al.,
1985; Sarafoff et al., 1986; Denielsen et al., 1988; Haesen et
al., 1988), as has the appearance of DNA aneuploid popula-
tions in HCC. However, for treatment with non-genotoxic
agents such as ciprofibrate, the nature and temporal
appearance relative to AHFs, NNs and HCCs of DNA
ploidy alterations has been less well studied. In the present
study, we have examined NNs, HCCs and adjacent non-
tumorous liver from rats treated with ciprofibrate, a potent
hypolipidaemic peroxisome proliferator, for changes in cel-
lular DNA content using flow cytometry methodology.
Materials and methods
Induction ofliver tumours
Eighteen male F-344 rats (Charles River Breeding Labor-
atories, Wilmington, MA, USA) at approximately 8 weeks of
age (80-100g) were started on a diet (Purina rat chow)
containing 0.025% (w/w) ciprofibrate (Sterling-Winthrop
Research Institute, Rensselaer, NY, USA). Animals were
sacrificed after 20 weeks (n = 4), 40 weeks (n = 4) or 20
months (n = 10) on the ciprofibrate diet. As control, six
animals were fed control diet (rat chow with no ciprofibrate)
for the same periods of time (n = 2 at each time point). At
necroscopy, multiple representative sections from each liver
were fixed in neutral buffered formalin and processed for
light microscopy.
Flow cytometric measurements
A haematoxylin-eosin (H&E)-stained section from each
paraffin block was examined before cutting 3-5 40-psm sec-
tions for isolation of nuclei. For control animals and
ciprofibrate-fed animals at 20 and 40 weeks, there were no
lesions or foci large enough for isolation and the entire tissue
was analysed (multiple samples were analysed per animal).
For ciprofibrate-fed animals at 20 months, the H&E section
was examined to identify areas that were predominantly NN,
HCC or normal tissue. Careful scoring of the block was then
done to allow isolation and separate processing of NNs,
HCCs or surrounding normal areas when sections were cut.
Samples were then processed for flow cytometric DNA
analysis by the method of Hedley et al., 1983), with slight
modifications. Briefly, sections were deparaffinised in xylene
and rehydrated through an alcohol series. The material was
then incubated in distilled water overnight, minced, digested
in 2 ml of 0.5% pepsin (Sigma, St Louis, MO, USA) in 0.9%
sodium chloride (pH 1.5) at 37°C for 30 min, sieved through
a 37 gtm mesh, and the pH neutralised. The sample was
washed in phosphate-buffered saline (PBS) and the concent-
ration adjusted to 106 cells ml-'. The cell suspension was
then treated as follows: washed, incubated for 3 min on ice in
PBS containing 0.1% Triton X-100 (Sigma), washed,
incubated at 37°C for 20min in PBS containing 180 units
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RNAase ml-' (Sigma), washed and resuspended in PBS con-
taining 0.3% polyethylene glycol (Research Products Interna-
tional, Mount Prospect, IL, USA) and 50 jig ml-' propidium
iodide (Calbiochem, San Diego, CA, USA). All samples were
examined microscopically for the presence of doublets, and if
more than 5% were seen samples were syringed through a 21
gauge needle until the proportion of doublets was less than
5%. Additionally, doublets were electronically removed from
analysis by gating on peak vs integral red fluorescence sig-
nals. All cell samples were analysed on the Coulter Elect-
ronics Profile II flow cytometer with PowerPak option
(Coulter Electronics, Hialeah, FL, USA) at the Veterans
Administration Lakeside Medical Center, collecting more
than 50000 events per sample. All samples were filtered
through a 37 lim nylon mesh just before analysis. Laser
excitation was 15 mW at 488 nm and the standard optical
filter configuration was used for red fluorescence light detec-
tion (488 nm dichroic, 457-502 nm long-pass laser blocking,
550 nm dichroic, 600 nm dichroic and 635 nm bandpass
filters). Cell cycle analysis was done using the Modfit analysis
routines (Verity Software House, Topsham, ME, USA), em-
ploying a single Gaussian function for each of the 2n, 4n, 8n
etc. peaks, single-cut debri and rectangular S-phase functions.
No population was classified as DNA aneuploid unless two
distinct Go/GI peaks were evident in the DNA content dist-
ribution (Hiddemann et al., 1984). A DNA tetraploid
population was defined as having a DNA index (DI) of
1.8-2.2 and a DNA octoploid population as having a DI of
3.6-4.4. A DNA tetraploid population was defined when the
percentage of G2/M, or tetraploid GO/GI peak, was greater
than 15% of the sum of [%Go/GI + %S + %G2/M (or DNA
tetraploid peak)] (Rabinovitch, 1993). A DNA octaploid
population was defined in an analogous manner. Since in
these conventional DNA ploidy definitions, DNA ploidy
class is defined by an artificial cut, abrupt changes in the
percentage of a given DNA ploidy class can occur. For
example, a sample with 16% 4n cells will be reported with
both DNA diploid and tetraploid populations, whereas a
sample with 14% 4n cells will be reported as 100% DNA
diploid. Thus, the percentage of 2n, 4n and 8n cells are also
reported. Since the DNA diploid or tetraploid G2/M popula-
tion overlaps with the DNA tetraploid or octaploid Go/GI
respectively, proliferative fraction (%S + %G2/M) data for
each DNA ploidy population are not reported. However, no
overlap of the S-phase fraction of each ploidy class occurs
and, thus, the weight-averaged S-phase was calculated for
each sample. Statistical comparisons of the percentage of
DNA diploid and percentage of 2n fractions were done using
the two-tailed Student's t-test.
Results
Livers from all control animals and the 20 week ciprofibrate-
fed animals appeared normal and did not contain any AHF,
NN or HCC lesions. Examination of the livers of the 40
week ciprofibrate-fed animals revealed only AHF, but no
nodules or HCC. These lesions were too small for separate
isolation for flow cytometric analysis. The livers of all ten
rats fed ciprofibrate for 20 months contained multiple grossly
visible lesions. Histological examination of liver sections
showed AHF, NN and HCC (Figures 1 and 2). The mor-
phological features of these different lesions have been des-
cribed previously (Rao et al., 1990). Representative NNs,
HCCs and NTC liver from each animal, based on H&E
sections, were carefully selected for flow cytometry. A total
of four NTCs, nine NNs and 27 HCCs were isolated.
The results for all animals fed control diet, regardless of
age, and for the 20 week and 40 week ciprofibrate-fed
animals was the same, showing either a predominant or
exclusively DNA diploid population. The range in the per
cent DNA diploid fraction for these samples was from
65-100% (data not shown).
Figure 3a and b shows typical results for an NTC and an
NN sample, respectively, from an animal-fed ciprofibrate for
20 months. Prominent DNA tetraploid and DNA diploid
populations are seen. All nine NNs had similar DNA ploidy
patterns and the results are summarised in Table I. In no
case were cell populations with a DI greater than 2.2 (>4c
DNA content) seen, nor were any DNA aneuploid (as dis-
tinct from DNA heteroploid) populations observed. A statis-
tically significant (P= 0.007) increase in the DNA diploid
fraction was seen in NNs (mean = 50% 4%) as compared
with non-tumorous adjacent areas (mean= 33% + 6%). This
difference is also reflected in the changes in average percen-
tage of 2n, 4n and 8n cells with a statistically significant
(P = 0.03) difference in percentage of 2n of NNs as compared
with the NTCs.
Figure 4 shows three representative results for HCC speci-
mens. A summary of HCC analyses are presented in Table I.
In Figure 4a a sample with multiple heteroploid cell popula-
Figure 1 Morphology of representative neoplastic nodules used
for flow cytometric analysis. (H&E x 150).
Figure 2 Morphology of representative hepatocellular carcinoma
used for flow cytometric analysis (H&E x 110).
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tions having DI of 1.0 (2c), 2.0 (4c), and 4.0 (8c) is shown. In
no samples were significant populations having DI greater
than 4.4 (8c) observed (see insert in Figure 4a). In Figure 4b,
an HCC sample with four DNA ploidy populations
(DI = 1.0, 1.8, 2.0 and 2.2) is shown. It should be noted that
the results for all NN and NTC samples were consistent with
DNA diploid or tetraploid populations. Seven of 27 HCC
samples exhibited cell populations with DNA ploidy values
(DI) distinct from those seen in NNs and NTCs. Addi-
tionally, five of seven of these HCC samples exhibited DNA
aneuploid populations as distinct from DNA heteroploid (i.e
consistent with 2c, 4c, 8c etc. DNA content). This is in
contrast to the NN samples and NTC adjacent areas in
which all populations were consistent with DNA heteroploid
populations. Again, a statistically significant increase in the
DNA diploid fraction (P = 0.003) and in the percentage of
2n (P = 0.004) as compared with surrounding NTC tissue
was seen.
Evaluation of the weight-averaged per cent S-phase cells is
shown in Table I. A trend to increasing average per cent
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S-phase was seen in the progression from NTCs to NNs to
HCCs with statistically significant differences seen in the
HCCs vs NTCs (P = 0.003) and HCCs vs NNs (P = 0.01)
groups. Within the NN samples, three of nine had average
per cent S-values greater than the NTC mean plus three
standard deviations as compared with 16/24 in the HCC
group.
Discussion
In this study, DNA ploidy alterations were investigated in a
rat model system of peroxisome proliferator-induced
hepatocellular carcinoma. Examination of nine 'premalig-
nant' NNs did not reveal the appearance of any new DNA
ploidy classes as compared with surrounding non-tumorous
controls (NTCs). Although, a significant increase in the frac-
tion of DNA diploid or 2n DNA content cells was seen as
compared with NTC. In examination of 27 hepatocellular
carcinoma samples (HCC), seven exhibited the appearance of
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Figure 3 Flow cytometric distributions showing number of
events vs red fluorescence (DNA content) for representative sam-
ples of non-tumorous surrounding tissue (a) and neoplastic
nodule (b).
Channel number (DNA content)
Channel number (DNA content)
Figure 4 Flow cytometric distributions showing number of
events vs red fluorescence (DNA content) for representative HCC
samples. Insert in (a) is HCC sample analysed at a lower
amplifier gain setting to illustrate the lack of significant cells with
DNA content greater than 8c.
Table I Summary of DNA ploidy and cell cycle data for NTC, NN and HCC samples
Sample Average per cent S Per cent diploid2 Per cent 2n Per cent tetraploit Per cent 4n Per cent octaploid1 Per cent 8n
NTC(n=4) 2.5±0.9 33±6 33±7 68±6 65±6 2±1
NN(n=9) 4.4±3.7 50±4 50±4 50±4 49±5 1±1
HCC(n=27) 9.9±9.lb 52±13 52±14 46±15 42±17 3±6 4±5
a As defined in Materials and methods. b Only 24/27 HCC samples were adequate for S-phase determinations.
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new DNA ploidy classes as compared with surrounding non-
tumorous areas. The same increase in DNA diploid or 2n
DNA content fraction as was seen in the NNs was observed
in HCCs. A trend to increasing S-phase cells with progres-
sion from NTC to NN to HCC was seen with three of nine
NN and 16/24 HCC samples having average per cent S
greater than the NTC mean plus three standard deviations.
Thus, these results do indicate an association of altered DNA
ploidy and increased per cent S-phase with progression to
HCC following treatment with a non-genotoxic peroxisome
proliferator.
The predominance of a DNA diploid population in all
control samples (20 weeks, 40 weeks or 20 months on control
diet) and in the 20 and 40 week ciprofibrate-fed animals is in
contrast with previous reports (Romagna and Zbinden, 1981;
Schwarze et al., 1984; Styles et al., 1985; Styles et al., 1988;
Wang et al., 1990) in which DNA tetraploid populations
were predominant. In these previous reports, either image
technology or cell isolation procedures that enriched the
parenchymal cells were used. However, in this study, no
enrichment of parenchymal cells was done. Thus, in these
samples in which the entire tissue was analysed (no isolatable
lesions were present), the results probably reflect the presence
of non-parenchymal (diploid) cells within the liver. Interest-
ingly, examination of the non-tumorous areas surrounding
the NN and HCC lesions in the 20 month ciprofibrate-fed
animals exhibited a more expected pattern with an average
per cent DNA diploid fraction of 33%. When comparing the
numbers from this study with others, it must be remembered
that these results reflect nuclear ploidy and not cellular
ploidy. Since this value is still somewhat on the high end of
reported values for normal rat liver, inclusion of some non-
parenchymal cells cannot be ruled out. Nonetheless, this is
still a dramatic difference as compared with the normal
control animals. Whether this reflects an effect of long-term
ciprofibrate feeding of the animals or an effect of the NN or
HCC on the surrounding normal tissue remains to be seen.
Although less likely differences in the recovery of paren-
chymal vs non-parenchymal cells in controls vs ciprofibrate-
fed animals cannot be ruled out. The preferential selection of
population has been reported when using the Hedley method
(Koss et al., 1989).
In the isolation of NN and HCC, careful dissection was
done to ensure that no normal tissue was included. Thus, the
problems discussed above concerning parenchymal vs non-
parenchymal cells does not apply. In both NNs and HCCs, a
significant increase in the per cent DNA diploid fraction was
seen as compared with NTC. It should be noted that even if
inclusion of non-parenchymal cells in the NTC did occur the
effect would be to mask rather than increase the differences
seen in the NNs and HCCs. As such, this shift appears to be
real and not an artifact of sample isolation and preparation.
This result is similar to that seen in AHF or NN following
treatment with a number of genotoxic agents (Schwarze et
al., 1984; Styles et al., 1985; Sarafoff et al., 1986; Denielsen et
al., 1988; Haesen et al., 1988). Additionally, treatment with
2-acetylaminofluorene alone (Klose et al., 1989) or N-
nitrosomorpholine (Romagna and Zbinden, 1981) results in
an increased diploid fraction. In contrast, studies with
dimethylnitrosamine treatment have reported a shift to an
increased tetraploid population (Digernes, 1983; Carlson and
Abraham, 1985). Thus, although there may be a few excep-
tions, these results, as with the majority of studies employing
genotoxic agents, would be consistent with a significant inc-
rease in the diploid fraction of cells being an early event in
the development of HCC in rats following treatment with
ciprofibrate. The average per cent S of the NNs, although
higher, was not statistically different than the surrounding
NTC.
The DNA ploidy alterations seen in the HCCs are similar
to other reports (Stich, 1960; Nowell et al., 1967; Becker et
al., 1971, 1973; Mori et al., 1982; Digernes, 1983; Styles et
al., 1985; Denielsen et al., 1988; Haesen et al., 1988). How-
ever, the frequency of DNA aneuploidy in this model of
HCC development is significantly lower (7/27) than has been
reported in a number of studies using genotoxic agents
(Stich, 1960; Nowell et al., 1967; Becker et al., 1971, 1973;
Mori et al., 1982). Although loss of DNA aneuploid popula-
tions has been seen with analysis of paraffin samples (Koss et
al., 1989), Digernes (1983) has also reported a low frequency
of aneuploidy in HCC, and a high degree of variability, even
among similar lesions in the same animal, has been reported
(Denielsen et al., 1988). The observation that progression to
HCC was frequently accompanied by an increased per cent
S-phase is not unexpected as increased proliferative fraction
is a negative prognostic indicator in a number of malignan-
cies (Bauer et al., 1993). However, it is interesting to note
that the increased frequency of lesions with higher per cent S
and altered DNA ploidy occurred together in this model
system. Correlation or association of increased per cent S in
DNA aneuploid tumours or karyotypically unstable popula-
tions has been observed (Chen et al., 1991; Waldman et al.,
1991; Steiner et al., 1993), and it has been hypothesised that
genetic changes may provide a proliferative advantage
(Volpe, 1990) and that accumulation of alterations are
associated with progression (Friend et al., 1988). However, it
should be noted that the low frequency of DNA aneuploid
HCC in this model system does not imply that karyotypic or
genetic instability is not still driving the process of progres-
sion to HCC (Sudilovsky et al., 1991).
Only limited conclusions can be drawn about the underly-
ing mechanisms of the genetic or DNA changes seen, since
the analyses done in this study were at the gross DNA ploidy
level, being insensitive to chromosomal changes involving
fewer than several chromosomes. However, certainly in liver,
a differentiated feature is the generation of tetraploid cells
implying that with differentiation in liver there is a block in
normal cytokinesis following cell replication, leading to the
generation of DNA tetraploid and higher ploidy populations.
With progression to malignancy there is a degree of loss of
this differentiated feature or block and an increase in the
diploid fraction of cells. This data would be consistent with
this block in normal cytokinesis no longer functioning in the
malignant cells. The appearance of non-integer DNA aneup-
loid populations does not occur until later in neoplastic
progression when presumably, as with other tumour types,
the loss of karyotype stability generates a wide range of both
chromosomal structural and numerical changes. Elucidation
of the primary mechanism (non-disjunction, etc.) underlying
this instability awaits chromosomal studies.
DNA aneuploidy is common in human HCC and appears
to be of prognostic value in patients (Popp and Marsman,
1991). The data examining DNA ploidy alterations in early
lesions during the development of human HCC is limited,
with reports of DNA aneuploidy being frequent in human
AHF (Thomas et al., 1992) and others reporting primarily
diploid cells in AHF (Hoso and Nakanuma, 1991). However,
the data suggest an earlier appearance of DNA aneuploidy in
human HCC than in HCC in rats induced either by PP or
genotoxic agents. It is mere speculation to hypothesise why
this might be the case. Access to early lesions in the rat
model system is far easier, and thus, even 'early' lesions in
human may be further progressed than the early lesions that
were examined in the rat. Clearly, the pattern of alterations
in rat HCC varies with causative agent and differences in the
primary causative agent might be related to the varying
course of DNA alterations seen in human cells as well.
Additionally, human cells are significantly more resistant to
malignant transformation in vitro than rodent cells, partic-
ularly with regard to immortalisation (Shay et al., 1989), and
thus, greater genetic alteration, manifested as DNA aneup-
loidy, may occur sooner. However, it must be stated again
that generation of DNA euploid malignant clones or foci is
not inconsistent with underlying genetic instability (Sudilov-
sky et al., 1991).
In conclusion, induction of HCC by the non-genotoxic
peroxisome proliferator, ciprofibrate, in rat results in a
significantly increased fraction of diploid cells in both NN
and HCC as compared with surrounding non-tumorous tis-
sue. As discussed above, this result is similar to results with aDNA analysis d hepatocelular carcinomas
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number of other hepatocarcinogens in the rat, and points to
this being an important early event in the development of
HCC in the rat. These early lesions did not exhibit a
significantly increased per cent S-phase cells. However.
careful assessment of the role of these changes in the earliest
AHF or NN and comparison with the parenchymal cells of
age-matched control animals or surrounding normal tissue
will require alternative techniques such as image analysis. As
has been generally found. HCC lesions exhibited an increased
frequency of DNA ploidy alterations. a result consistent with
continued genetic instability with progression to HCC. Addi-
tionally, a correlation of increased per cent S in the HCC
lesions was also found.
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